Employees: NN (None)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2018-03-15 (8 years)Status: ActiveBusiness sector: Production de combustibles gazeuxLocation: GOGNEY (54450), Meurthe-et-Moselle
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SALIERES BIO NRJ : revenue, balance sheet and financial ratios
SALIERES BIO NRJ is a French company
founded 8 years ago,
specialized in the sector Production de combustibles gazeux.
Based in GOGNEY (54450),
this company of category PME
shows in 2025 a net income positive of 32 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SALIERES BIO NRJ (SIREN 838221588)
Indicator
2025
2024
2023
2021
Revenue
N/C
N/C
N/C
N/C
Net income
31 713 €
104 724 €
148 473 €
46 189 €
EBITDA
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SALIERES BIO NRJ generates positive net income of 32 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2025: 46 k€ -> 32 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
31 713 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 391%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 19%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
391.361%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
18.649%
Solvency indicators evolution SALIERES BIO NRJ
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2023
2024
2025
Debt ratio
1099.694
513.435
424.579
391.361
Financial autonomy
7.769
15.492
17.728
18.649
Repayment capacity
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
Sector positioning
Debt ratio
391.362025
2023
2024
2025
Q1: 206.84
Med: 365.3
Q3: 636.67
Average-13 pts over 3 years
In 2025, the debt ratio of SALIERES BIO NRJ (391.36) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
18.65%2025
2023
2024
2025
Q1: 12.02%
Med: 20.49%
Q3: 32.24%
Average
In 2025, the financial autonomy of SALIERES BIO NRJ (18.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Positioning of SALIERES BIO NRJ in its sector
Comparison with sector Production de combustibles gazeux
Valuation estimate
Based on 127 transactions of similar company sales
(all years),
the value of SALIERES BIO NRJ is estimated at
87 835 €
(range 18 553€ - 319 909€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
127 transactions
18k€87k€319k€
87 835 €Range: 18 553€ - 319 909€
Section all-time
Aggregated at NAF section level
Valuation method used
Net Income Multiple
31 713 €
×
2.8x
=87 835 €
Range: 18 554€ - 319 909€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 127 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Production de combustibles gazeux)
Compare SALIERES BIO NRJ with other companies in the same sector:
The revenue of SALIERES BIO NRJ is not publicly disclosed (confidential accounts filed with INPI).
Is SALIERES BIO NRJ profitable?
Yes, SALIERES BIO NRJ generated a net profit of 32 k€ in 2025.
Where is the headquarters of SALIERES BIO NRJ ?
The headquarters of SALIERES BIO NRJ is located in GOGNEY (54450), in the department Meurthe-et-Moselle.
Where to find the tax return of SALIERES BIO NRJ ?
The tax return of SALIERES BIO NRJ is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SALIERES BIO NRJ operate?
SALIERES BIO NRJ operates in the sector Production de combustibles gazeux (NAF code 35.21Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart